WO2001050214A2 - Methods for collecting genetic material - Google Patents
Methods for collecting genetic material Download PDFInfo
- Publication number
- WO2001050214A2 WO2001050214A2 PCT/EP2000/013355 EP0013355W WO0150214A2 WO 2001050214 A2 WO2001050214 A2 WO 2001050214A2 EP 0013355 W EP0013355 W EP 0013355W WO 0150214 A2 WO0150214 A2 WO 0150214A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- information
- genetic material
- individual
- payment
- supplier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/20—Heterogeneous data integration
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
Definitions
- This invention relates to methods, e.g., computer-based methods, for collecting information and material.
- this invention relates to methods for collecting medical and genetic information and material.
- the collections of genetic material currently held by pharmaceutical companies and other entities are, for the most part, obtained from isolated or narrowly specified populations, e.g., a population of individuals afflicted with a particular disease and their blood relatives or a population of individuals in a selected community or ethnic group. Accordingly, current collections of genetic material are generally derived from populations where a large founder effect is expected. It is rather unlikely that such collections of genetic material are representative of the worldwide population of disease related genes.
- the analysis of collections of genetic material obtained from isolated populations has led to the identification of genes associated with several monogenic diseases. For example, researchers recently reported that mutations in a gene called AIRE are associated with autoimmune polyglandular syndrome type I (APS 1 ), a rare autosomal recessive disorder that maps to human chromosome 21.
- Genetic information can be used to develop new diagnostic assays, new therapeutic regimes, and individually tailored therapeutic regimes. This genetics- based approach to disease diagnosis and treatment is widely expected to revolutionize health care. However, this genetic-based approach is likely to be fully realized only after sequencing significant portions of the genomes of a diverse population of individuals.
- genetic material be first collected from a diverse population of individuals. It is important that the collected genetic material be associated with information about the individual from which it has been collected.
- the associated information can include such basic information as the individual's age, gender, and place of residence. It can also include detailed medical information, both present and historical.
- the present invention provides a method and system for an information collector to collect information from information suppliers and to provide an incentive for the information suppliers to provide the information.
- the method and system are suitable for gathering many types of information, and are particularly useful for gathering information that increases in value over time or at least has the potential to increase in value over time.
- the method of the invention which is typically implemented using a server computer system and a client computer system, entails rewarding each information supplier with an ownership share in value created by or associated with the information provided by the aggregate of information suppliers, e.g., by giving an information supplier with a ownership share or an option to purchase an ownership share in an entity having rights in the information provided by the information supplier.
- the system and method of the invention can be implemented using a computer system accessible for on-line interactive communication.
- the method of the invention makes it feasible for an information collector to obtain a considerable amount of information at relatively little present cost. This is particularly valuable where the value of the information provided by each information supplier is, at the time it is collected, of little value or an indeterminate value, at least to the information collector.
- information that is of little value or indeterminate value to the information collector can be of value to the information supplier.
- the information supplier may require an incentive, e.g., a payment, to provide the information to the information collector.
- an incentive e.g., a payment
- This disequilibrium makes it difficult to set a payment for the information supplied by an individual information supplier that is acceptable to both the information collector and the information supplier.
- the methods of the invention address this problem by granting information suppliers an ownership share or an option on an ownership share in an entity having rights in the information collected.
- the methods of the invention are quite useful where an information supplier requires or prefers an incentive to incur the cost of providing the information. This cost might be, e.g., the time required to provide the information, the loss of privacy associated with providing the information, or the loss of the exclusive use of the information.
- An information supplier that is rewarded with an ownership share or an option on an ownership share in an entity having rights in the information collected has an incentive to provide complete and accurate information.
- the information supplier has an ownership share in an entity or body of information which may grow in value over time, the information supplier has an incentive to both remain in contact with the information collector and to provide additional information.
- the incentive given to an information supplier in exchange for the information provided is akin to an ownership share or an option on an ownership share in an entity that possesses or has rights in the provided information. Since the entity will typically possess information from a large number of individual suppliers and because the value of the aggregate information can be much higher than the value of the information obtained from each individual supplier or even the sum of the values of the information obtained from each of the individual suppliers, an ownership share in the entity can be of significant value. In addition, because the value of certain types of information grows over time, the providing of information in exchange for an ownership share or an option on an ownership share in the aggregate information can be a form of investment.
- the method of the invention is used to obtain medical information and genetic material.
- the method can be implemented using a computer system that includes a server system and a client system.
- the method can be implemented using interconnected computers that exchange information using services such as electronic mail or the World Wide Web ("WWW").
- WWW World Wide Web
- the method of the invention can be implement by any means of communication, e.g., by conventional mail or by telephone.
- a client system displays a questionnaire designed to elicit identification information and medical information from an information supplier, eg., in the form of a Web page which is sent from a server system to a client system.
- the information supplier electronically completes or partially completes the questionnaire.
- the information is sent from the client system to the server system, where it is analyzed for sufficiency.
- the server system then issues an order to send a genetic material collection kit to the information supplier along with instructions for using the kit and returning the kit to an information collector.
- the server system also issues a unique identifier which can be used to a associate the genetic material with the identification and medical information provided by the information supplier.
- the "kit” can be sent electronically because it can be in the form of instructions for collecting and transmitting a biological sample containing DNA.
- the genetic material can be any suitable biological sample, e.g., a sample of hair, blood or saliva.
- the methods of the invention are particularly adapted to collecting this type of information. Although it is possible to sequence part or all of the DNA recovered from a small biological sample, it is not presently cost effective to sequence significant portions of the DNA obtained from a large number of individuals. However, automated sequencing methods will rapidly reduce the cost of carrying out such sequencing. This reduction in cost will make it feasible to sequence significant portions of the DNA of numerous individuals. Thus, the value of a collection of genetic material (i.e., biological material containing DNA) will increase in value.
- the methods of the invention are useful for building a database of genetic material and rewarding the suppliers of the genetic material.
- the suppliers of the genetic material and medical information by exchanging the genetic material and medical information for a share in the value of the aggregate information, are each making an investment in the value of a genetic database that will, over time, become increasingly useful in medical research and thus, increasingly valuable.
- the invention features a method for obtaining genetic material from a plurality of individuals.
- the methods includes: (a) providing on-line access to a questionnaire comprising a plurality of questions; (b) providing on-line access to a genetic material collection kit request form; (c) allowing an individual to electronically complete the questionnaire; (d) allowing an individual to electronically complete the genetic material collection kit request from; (e) in response to completion the request form, providing each individual with: (1) a genetic material collection kit including instructions for providing a sample of genetic material from the individual and transmitting the provided sample to a collector of genetic material; and (2) a unique identifier which matches the sample of genetic material to the completed questionnaire; and (f) obtaining the transmitted genetic material provided by the individual, whereby genetic material is obtained from the plurality of individuals.
- the method includes making a payment to the individual upon obtaining the transmitted genetic material.
- the payment can include an option to purchase an ownership share in an entity possessing the genetic material transmitted by the individual an ownership share in an entity possessing the genetic material provided by the individual, the payment to each individual comprising the plurality of individuals is the same, and the payment to at least a first individual in the plurality of individuals differs from the payment to a second individual in the plurality of individuals.
- Figure 1 illustrates a system for collecting genetic and medical information.
- Figure 2 illustrates a genetic material collection kit.
- Figure 3 illustrates one embodiment of a hierarchical data entry form.
- Figure 4 illustrates one embodiment of a hierarchical data entry form with the Identification Information section expanded (shown in part only).
- Figure 5 illustrates one embodiment of a hierarchical data entry form with the Medical History section expanded (shown in part only).
- the present invention provides a method and system for collecting information from information suppliers.
- the system of the present invention provides an incentive for information suppliers to provide complete and accurate information and is particularly useful for obtaining information that is, at the time it is collected, of low or indeterminate value.
- the system of the invention provides a cost-effective means for obtaining such information by exchanging the information for a payment that is linked, directly or indirectly, to either the value of the information provided by the information supplier or the aggregate value of the information provided by a plurality of information suppliers or both. This is accomplished, e.g., by granting information suppliers with an ownership share or an option on an ownership share in an entity having rights in the information collected or by granting information suppliers with an ownership share or an option on an ownership share in the mformation collected.
- the value of the payment made to information suppliers can increase over time as well. Because the value of the information obtained from an individual can increase as the total number of individuals providing information grows, the value of the payment made to an individual can grow as additional individual information suppliers provide information.
- FIG. 7 is a flow diagram illustrating an embodiment of the invention used to collect medical information and genetic material.
- the information collector sends a medical questionnaire to a potential information supplier. This can be accomplished by causing a server computer system send a web page to a client computer system.
- an information supplier completes the questionnaire, e.g., by completing data fields in web page sent to client computer system.
- the information supplier returns the completed questionnaire to the information collector, e.g., by sending a electronic message to the server computer system.
- the information collector sends a genetic sample collection kit to the information supplier.
- the kit can be used to collect any biological sample containing the information supplier's DNA.
- the kit can be used to collect a sample of hair, a sample of blood, or a sample of saliva.
- the collection kit will be accompanied by instructions for collecting the sample.
- the information supplier will be sent a unique identifier which is used to link the information provided in response to the questionnaire with the genetic material.
- the genetic sample collection kit can be sent to the information supplier electronically, e.g., as a web page sent to a client server system. Such electronically transmitted kits are in the form of instructions for collecting a genetic sample.
- the information supplier collects a genetic sample using the genetic sample kit.
- the information supplier sends the collected genetic sample to the information collector.
- the information collector issues a payment to the information supplier. This payment can include a share in or an option to purchase a share in an entity having rights in the information provided.
- Figure 2 illustrates a simple genetic sample collection kit that can be electronically transmitted to an information supplier for collecting a sample of, e.g., saliva.
- the kit is a piece of paper 210 marked with a target 220 for spitting onto.
- the target 220 is sized such that when covered with saliva, sufficient DNA is deposited on the paper for extraction and sequencing.
- the piece of paper 210 can be folded along lines 230 to protect the sample.
- the piece of paper will also be marked with the unique identifier.
- the marked piece of paper can be created by the information supplier using instructions transmitted electronically or can be printed from a web page transmitted to a client computer system.
- the information supplier will be provided with instructions for collecting a saliva sample. For example, the supplier might be instructed to not collect the saliva sample immediately after food or beverage (other than water) intake.
- the supplier might be instructed to drink a glass of water, wait five minutes, place the collection paper on a flat surface, spit onto the paper so as to fill the target with saliva, allow the saliva to dry, fold the paper, and place the folded paper in an envelope and send it to a particular address.
- the data entry for the medical questionnaire as implemented on a Web page can be in the form of a hierarchical data entry form.
- This type of form is useful where, as often the case, the entire questionnaire cannot fit on the user's display at one time without scrolling. When this happens, it can be difficult for the user to understand the nature and organization of the information to be entered. Moreover, completion of the questionnaire can appear to be a more difficult and time-consuming process than is actually the case.
- Figure 3 illustrates one embodiment of a hierarchical data entry form with various sections identified by their title: Identification Information 301, Medical History 302, Medical History of Relatives 303, Environmental Information 304.
- the Identification Information section 301 when the user selects the Identification Information section 301, that section expands to display data entry fields for basic identification information such as age 401, gender 402, height 403, weight 404, country of residence 405, country of birth 406, and e-mail address 407.
- reply buttons e.g., for replying "yes” or "no” can be used in the place of a data entry field.
- the other sections remain unexpanded, yet visible in title form 302, 303, and 304.
- the user can click on the title of another section, e.g., the Medical History section 302.
- the selected section will expand and the other sections will be visible in title form 301, 302, and 304.
- Figure 5 illustrates a portion of the display when the Medical History section 302 has been expanded.
- the Medical History section contains data entry fields for responding to inquiries about various medical conditions, e.g., speech impairment 501, hearing impairment 502, vision impairment 503, and diabetes 504.
- Reply buttons can replace the data entry fields, as shown. Of course, may more questions can be asked. Replies to some questions, or even all questions, can be optional.
- a payment can be made to the information supplier once the information has been sent to the information collector.
- the payment can be in any form.
- the preferred payment is an ownership share or an option to purchase an ownership share in an entity possessing or having rights in the information collected.
- the value of the payment can vary. For example, an information supplier who provides very complete information could receive a payment that is greater than an information supplier who provides relatively incomplete information. For example an information supplier who provides relatively complete information could receive a lower cost option than an information supplier who provides less complete information. It might also be useful to vary the payment depending on the nature of the information provided. For example, in the context of medical information and genetic material, it might be relatively difficult to obtain information and material from individuals suffering from a relatively rare disease.
- the medical information and genetic material obtained from these individuals can be of relatively high value. Accordingly, an information supplier suffering from a rare disease could receive a greater payment than one who does not. It may also be desirable to make the size of the payment dependent on the timing of the receipt of the information provided by the information supplier. For example, in order to give information suppliers an incentive for providing information at an early time, the payment given in exchange for the information provided could decrease over time. In a variation on this approach, the payment made to an information supplier would vary depending on how many information suppliers have already provided information. For example, an information supplier who provides information after 10,000 other information suppliers have already provided information might receive a lesser payment than an information supplier who provides information after only 1,000 other information suppliers have provided information.
- identification information i.e., the information that could link the provider to the genetic material or to the medical information. Accordingly, the various databases can be maintained separately. In addition, a party that does not have access to the databases themselves could hold the identification codes which link identification information, medical information, and genetic material.
- Those skilled in the art will be aware of various methods that can be used to protect the privacy of information suppliers. A number of embodiments of the mvention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Databases & Information Systems (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioethics (AREA)
- Business, Economics & Management (AREA)
- Accounting & Taxation (AREA)
- Development Economics (AREA)
- Finance (AREA)
- Strategic Management (AREA)
- Entrepreneurship & Innovation (AREA)
- Game Theory and Decision Science (AREA)
- Economics (AREA)
- Marketing (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU23709/01A AU2370901A (en) | 1999-12-30 | 2000-12-27 | Methods for collecting genetic material |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47554099A | 1999-12-30 | 1999-12-30 | |
| US09/475,540 | 1999-12-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001050214A2 true WO2001050214A2 (en) | 2001-07-12 |
| WO2001050214A3 WO2001050214A3 (en) | 2002-06-13 |
Family
ID=23888030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2000/013355 Ceased WO2001050214A2 (en) | 1999-12-30 | 2000-12-27 | Methods for collecting genetic material |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2370901A (en) |
| WO (1) | WO2001050214A2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7797302B2 (en) | 2007-03-16 | 2010-09-14 | Expanse Networks, Inc. | Compiling co-associating bioattributes |
| US8788286B2 (en) | 2007-08-08 | 2014-07-22 | Expanse Bioinformatics, Inc. | Side effects prediction using co-associating bioattributes |
| US9031870B2 (en) | 2008-12-30 | 2015-05-12 | Expanse Bioinformatics, Inc. | Pangenetic web user behavior prediction system |
| US10726098B2 (en) | 2014-01-23 | 2020-07-28 | Dror Samuel Brama | Method, system and program product for transferring genetic and health data |
| US11657902B2 (en) | 2008-12-31 | 2023-05-23 | 23Andme, Inc. | Finding relatives in a database |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6640211B1 (en) * | 1999-10-22 | 2003-10-28 | First Genetic Trust Inc. | Genetic profiling and banking system and method |
-
2000
- 2000-12-27 WO PCT/EP2000/013355 patent/WO2001050214A2/en not_active Ceased
- 2000-12-27 AU AU23709/01A patent/AU2370901A/en not_active Abandoned
Cited By (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11581098B2 (en) | 2007-03-16 | 2023-02-14 | 23Andme, Inc. | Computer implemented predisposition prediction in a genetics platform |
| US11600393B2 (en) | 2007-03-16 | 2023-03-07 | 23Andme, Inc. | Computer implemented modeling and prediction of phenotypes |
| US7933912B2 (en) | 2007-03-16 | 2011-04-26 | Expanse Networks, Inc. | Compiling co-associating bioattributes using expanded bioattribute profiles |
| US7941329B2 (en) | 2007-03-16 | 2011-05-10 | Expanse Networks, Inc. | Insurance optimization and longevity analysis |
| US7941434B2 (en) | 2007-03-16 | 2011-05-10 | Expanse Networks, Inc. | Efficiently compiling co-associating bioattributes |
| US8024348B2 (en) | 2007-03-16 | 2011-09-20 | Expanse Networks, Inc. | Expanding attribute profiles |
| US8051033B2 (en) | 2007-03-16 | 2011-11-01 | Expanse Networks, Inc. | Predisposition prediction using attribute combinations |
| US8099424B2 (en) | 2007-03-16 | 2012-01-17 | Expanse Networks, Inc. | Treatment determination and impact analysis |
| US8209319B2 (en) | 2007-03-16 | 2012-06-26 | Expanse Networks, Inc. | Compiling co-associating bioattributes |
| US11348692B1 (en) | 2007-03-16 | 2022-05-31 | 23Andme, Inc. | Computer implemented identification of modifiable attributes associated with phenotypic predispositions in a genetics platform |
| US12243654B2 (en) | 2007-03-16 | 2025-03-04 | 23Andme, Inc. | Computer implemented identification of genetic similarity |
| US12106862B2 (en) | 2007-03-16 | 2024-10-01 | 23Andme, Inc. | Determination and display of likelihoods over time of developing age-associated disease |
| US10379812B2 (en) | 2007-03-16 | 2019-08-13 | Expanse Bioinformatics, Inc. | Treatment determination and impact analysis |
| US11791054B2 (en) | 2007-03-16 | 2023-10-17 | 23Andme, Inc. | Comparison and identification of attribute similarity based on genetic markers |
| US10803134B2 (en) | 2007-03-16 | 2020-10-13 | Expanse Bioinformatics, Inc. | Computer implemented identification of genetic similarity |
| US10896233B2 (en) | 2007-03-16 | 2021-01-19 | Expanse Bioinformatics, Inc. | Computer implemented identification of genetic similarity |
| US10957455B2 (en) | 2007-03-16 | 2021-03-23 | Expanse Bioinformatics, Inc. | Computer implemented identification of genetic similarity |
| US10991467B2 (en) | 2007-03-16 | 2021-04-27 | Expanse Bioinformatics, Inc. | Treatment determination and impact analysis |
| US7818310B2 (en) | 2007-03-16 | 2010-10-19 | Expanse Networks, Inc. | Predisposition modification |
| US11348691B1 (en) | 2007-03-16 | 2022-05-31 | 23Andme, Inc. | Computer implemented predisposition prediction in a genetics platform |
| US8606761B2 (en) | 2007-03-16 | 2013-12-10 | Expanse Bioinformatics, Inc. | Lifestyle optimization and behavior modification |
| US11482340B1 (en) | 2007-03-16 | 2022-10-25 | 23Andme, Inc. | Attribute combination discovery for predisposition determination of health conditions |
| US11495360B2 (en) | 2007-03-16 | 2022-11-08 | 23Andme, Inc. | Computer implemented identification of treatments for predicted predispositions with clinician assistance |
| US11515047B2 (en) | 2007-03-16 | 2022-11-29 | 23Andme, Inc. | Computer implemented identification of modifiable attributes associated with phenotypic predispositions in a genetics platform |
| US11735323B2 (en) | 2007-03-16 | 2023-08-22 | 23Andme, Inc. | Computer implemented identification of genetic similarity |
| US11545269B2 (en) | 2007-03-16 | 2023-01-03 | 23Andme, Inc. | Computer implemented identification of genetic similarity |
| US11581096B2 (en) | 2007-03-16 | 2023-02-14 | 23Andme, Inc. | Attribute identification based on seeded learning |
| US7797302B2 (en) | 2007-03-16 | 2010-09-14 | Expanse Networks, Inc. | Compiling co-associating bioattributes |
| US11621089B2 (en) | 2007-03-16 | 2023-04-04 | 23Andme, Inc. | Attribute combination discovery for predisposition determination of health conditions |
| US8788286B2 (en) | 2007-08-08 | 2014-07-22 | Expanse Bioinformatics, Inc. | Side effects prediction using co-associating bioattributes |
| US11003694B2 (en) | 2008-12-30 | 2021-05-11 | Expanse Bioinformatics | Learning systems for pangenetic-based recommendations |
| US11514085B2 (en) | 2008-12-30 | 2022-11-29 | 23Andme, Inc. | Learning system for pangenetic-based recommendations |
| US9031870B2 (en) | 2008-12-30 | 2015-05-12 | Expanse Bioinformatics, Inc. | Pangenetic web user behavior prediction system |
| US11657902B2 (en) | 2008-12-31 | 2023-05-23 | 23Andme, Inc. | Finding relatives in a database |
| US11776662B2 (en) | 2008-12-31 | 2023-10-03 | 23Andme, Inc. | Finding relatives in a database |
| US11935628B2 (en) | 2008-12-31 | 2024-03-19 | 23Andme, Inc. | Finding relatives in a database |
| US12100487B2 (en) | 2008-12-31 | 2024-09-24 | 23Andme, Inc. | Finding relatives in a database |
| US10726098B2 (en) | 2014-01-23 | 2020-07-28 | Dror Samuel Brama | Method, system and program product for transferring genetic and health data |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001050214A3 (en) | 2002-06-13 |
| AU2370901A (en) | 2001-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20020019746A1 (en) | Aggregating persons with a select profile for further medical characterization | |
| US7984079B2 (en) | System and method for electronically managing medical data files | |
| Speer et al. | Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7 | |
| US20170372015A1 (en) | Transfusion Registry Network Providing Real-time Interaction Between Users and Providers of Genetically Characterized Blood Products | |
| Collin et al. | Homozygosity mapping of Alström syndrome to chromosome 2p | |
| US8107693B2 (en) | Artificial intelligence system for genetic analysis | |
| CA2420717C (en) | Artificial intelligence system for genetic analysis | |
| CA2420717E (en) | Artificial intelligence system for genetic analysis | |
| US20120203466A1 (en) | System and method for identifying disease-influencing genes | |
| Castellino | When the chips are down | |
| CA2329598A1 (en) | Method and apparatus for the management of data files | |
| US20050086011A1 (en) | Information processing system using nucleotide sequence-related information | |
| US8078407B1 (en) | System and method for identifying disease-influencing genes | |
| WO2003009210A1 (en) | Methods of providing customized gene annotation reports | |
| WO2001050214A2 (en) | Methods for collecting genetic material | |
| Cordeiro et al. | The GM2 gangliosidoses datanases: allelic variation at the HEXA, HEXB, and GMWA gene loci | |
| JP2004005248A (en) | Body information management system | |
| KR20050026016A (en) | Apparatus for forming molecular timetable and appratus for estimating circadian clock | |
| JP3324594B2 (en) | Bio product quality assurance method and bio information distribution method | |
| Ouellette | Internet resources for the clinical geneticist | |
| O'Brien et al. | DNA fingerprints from Mycobacterium tuberculosis isolates of patients confined for therapy noncompliance show frequent clustering | |
| EP1111525A2 (en) | A method of guaranteeing the quality of a product with biotechnology and a method of delivering gene information | |
| Wallace | The potential of population surveys for genetic studies | |
| Van Steensel et al. | Internet databases for clinical geneticists‐an overview 1 | |
| Lei et al. | Gateway to bioinformatics: the Internet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO COMMUNICATION= FORM 1205A DATED: 11.06.2003) |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |